A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

NCT06401330 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1656

Enrollment

NETWORK

Sponsor class

Conditions

Stage I Mixed Cell Type Kidney Wilms Tumor
Stage II Mixed Cell Type Kidney Wilms Tumor
Stage III Mixed Cell Type Kidney Wilms Tumor
Stage IV Mixed Cell Type Kidney Wilms Tumor

Interventions

PROCEDURE: Bone Scan
DRUG: Carboplatin
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
BIOLOGICAL: Dactinomycin
DRUG: Doxorubicin
DRUG: Etoposide
DRUG: Irinotecan
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Nephrectomy
OTHER: Patient Observation
PROCEDURE: Positron Emission Tomography
PROCEDURE: Ultrasound Imaging
DRUG: Vincristine
PROCEDURE: X-Ray Imaging

Sponsor

Children's Oncology Group